End-of-day quote
Ghana S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
1.5
GHS
|
0.00%
|
|
0.00%
|
0.00%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
1,054
|
1,223
|
666.2
|
587.8
|
713.2
|
674
|
Enterprise Value (EV)
1 |
1,036
|
1,241
|
777.8
|
903.3
|
901.6
|
537.5
|
P/E ratio
|
16.2
x
|
14.9
x
|
6.31
x
|
6.52
x
|
7.22
x
|
5.44
x
|
Yield
|
1.04%
|
1.35%
|
2.65%
|
3%
|
2.58%
|
3.26%
|
Capitalization / Revenue
|
0.26
x
|
0.24
x
|
0.11
x
|
0.12
x
|
0.09
x
|
0.03
x
|
EV / Revenue
|
0.25
x
|
0.24
x
|
0.12
x
|
0.19
x
|
0.12
x
|
0.03
x
|
EV / EBITDA
|
9.65
x
|
8.27
x
|
3.96
x
|
4.96
x
|
4.59
x
|
2.23
x
|
EV / FCF
|
-15.3
x
|
-27.1
x
|
-7.54
x
|
-4.11
x
|
7.52
x
|
1.74
x
|
FCF Yield
|
-6.55%
|
-3.69%
|
-13.3%
|
-24.3%
|
13.3%
|
57.5%
|
Price to Book
|
2.87
x
|
2.79
x
|
1.26
x
|
0.98
x
|
1.04
x
|
0.85
x
|
Nbr of stocks (in thousands)
|
391,863
|
391,863
|
391,863
|
391,863
|
391,863
|
391,863
|
Reference price
2 |
2.690
|
3.120
|
1.700
|
1.500
|
1.820
|
1.720
|
Announcement Date
|
3/28/18
|
4/26/19
|
5/27/20
|
5/12/21
|
4/20/22
|
6/6/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
4,079
|
5,092
|
6,265
|
4,838
|
7,537
|
20,744
|
EBITDA
1 |
107.3
|
150.2
|
196.2
|
182.3
|
196.3
|
241.2
|
EBIT
1 |
78.44
|
116.7
|
146.7
|
139.8
|
145.5
|
178.3
|
Operating Margin
|
1.92%
|
2.29%
|
2.34%
|
2.89%
|
1.93%
|
0.86%
|
Earnings before Tax (EBT)
1 |
84.52
|
114.1
|
151.5
|
118.9
|
141.4
|
173.3
|
Net income
1 |
65.09
|
81.95
|
105.5
|
90.21
|
98.74
|
123.9
|
Net margin
|
1.6%
|
1.61%
|
1.68%
|
1.86%
|
1.31%
|
0.6%
|
EPS
2 |
0.1661
|
0.2091
|
0.2693
|
0.2302
|
0.2520
|
0.3162
|
Free Cash Flow
1 |
-67.89
|
-45.77
|
-103.1
|
-219.7
|
119.8
|
308.9
|
FCF margin
|
-1.66%
|
-0.9%
|
-1.65%
|
-4.54%
|
1.59%
|
1.49%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
61.05%
|
128.08%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
121.36%
|
249.31%
|
Dividend per Share
2 |
0.0280
|
0.0420
|
0.0450
|
0.0450
|
0.0470
|
0.0560
|
Announcement Date
|
3/28/18
|
4/26/19
|
5/27/20
|
5/12/21
|
4/20/22
|
6/6/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
18.6
|
112
|
315
|
188
|
-
|
Net Cash position
1 |
18.1
|
-
|
-
|
-
|
-
|
136
|
Leverage (Debt/EBITDA)
|
-
|
0.124
x
|
0.5689
x
|
1.731
x
|
0.96
x
|
-
|
Free Cash Flow
1 |
-67.9
|
-45.8
|
-103
|
-220
|
120
|
309
|
ROE (net income / shareholders' equity)
|
19.2%
|
20.3%
|
21.8%
|
16%
|
15.4%
|
16.8%
|
ROA (Net income/ Total Assets)
|
5.15%
|
6.12%
|
5.99%
|
4.58%
|
3.95%
|
3.14%
|
Assets
1 |
1,265
|
1,339
|
1,761
|
1,971
|
2,497
|
3,951
|
Book Value Per Share
2 |
0.9400
|
1.120
|
1.350
|
1.530
|
1.750
|
2.010
|
Cash Flow per Share
2 |
0.1600
|
0.2300
|
0.3500
|
0.1900
|
0.2400
|
1.030
|
Capex
1 |
149
|
176
|
203
|
352
|
247
|
272
|
Capex / Sales
|
3.65%
|
3.46%
|
3.24%
|
7.28%
|
3.27%
|
1.31%
|
Announcement Date
|
3/28/18
|
4/26/19
|
5/27/20
|
5/12/21
|
4/20/22
|
6/6/23
|
|
1st Jan change
|
Capi.
|
---|
| 0.00% | 43.61M | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|